ArticleAnnals of medicine2026

Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis.

Yuxiu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.